PHARMA 2100 ApS: Financial statements 2014
CVR: 26382785
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
PHARMA 2100 ApS (CVR 26382785) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -5,348 and a net result of DKK -5,348 compared with DKK -25,250 the year before. Equity in the 2014 report amounted to DKK 51,992. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -5,348
- Profit/Loss
- DKK -5,348
- Equity
- DKK 51,992
- Total Assets
- DKK 51,992
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 0 | -5 t. | -5 t. | 52 t. | - |
| 2013 | 0 | -250 | -25 t. | 57 t. | - |
| 2012 | 0 | 0 | -50 t. | 83 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of December 19, 2014, Bella da Silva Buxbom is registered as chairman of PHARMA 2100 ApS.
As of December 19, 2014, Jens Meidahl has stepped down as chairman of PHARMA 2100 ApS.
About PHARMA 2100 ApS
PHARMA 2100 ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company has been dissolved on 23 October 2018. The company was registered under the industry Industriel design og produktdesign. The company has 1 employee (2009). In 2017, the company reported a gross profit of DKK -20,455 and a net result of DKK -20,455 compared with DKK 0 the year before. Equity in the 2017 report amounted to DKK 29,371.